CIK 0000822370 · Non-accelerated filer<br>Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870419387
- Phone
- 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 4 Grant or award Director acquired 1,000,000 shares (grant or award)
- 4 Grant or award Director acquired 250,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 1,000,000 shares (grant or award)
- 4 Grant or award Director acquired 250,000 shares (grant or award)
- 4 Grant or award Director acquired 250,000 shares (grant or award)
- 4 Grant or award Director acquired 250,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 1,000,000 shares (grant or award)
- 4 Grant or award Director acquired 500,000 shares (grant or award)
- 4 Grant or award Director acquired 250,000 shares (grant or award)
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- NT 10-Q Other NT 10-Q
- 10-Q Report Quarterly Report
- D/A Other Amended Notice of Exempt Offering of Securities
- 10-K Report Annual Report
Page 32 of 63 · 1,250 filings